Gene Query: IL24

Dataset Description Geneva Score
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 185.0
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 120.51
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 111.11
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 104.08
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 89.06
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 70.53
Neurofibroma 70.53
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 60.16
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 55.98
Anti-inflammatory effect of indoleacrylic acid (IA) 54.77
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 47.33
RNA-seq of MDA-MB-231 cells with TET1 knockout 47.14
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 46.1
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 46.1
Regulation of hypoxia-inducible factor activity by ZMYND8 45.82
Transcriptional effect of ETV1 knockdown in melanoma cells 42.64
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 40.87
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 38.9
MARCKS and lnc-MARCKS act as inflammation regulators 32.74
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 31.45
Regulatory network controlling tumor-promoting inflammation in human cancers 30.92
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 30.92
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 30.78
Fbxo32 mediated gene expression program underlies EMT and metastasis 30.64
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 29.19
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 28.69
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 28.69
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 28.53
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 28.53
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 25.68
Spliceosomal disruption of the non-canonical BAF complex in cancer 25.52
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 24.82
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 24.41
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 24.14
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 23.99
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 23.46
IRF2 is a master regulator of human keratinocyte stem cell fate 23.46
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 23.03
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 22.9
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 22.49
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 20.75
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 19.98
RNA-seq of cells with TET1 knockout 19.25
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 18.28
Transcriptional profiles of normal human mature B cells 17.49
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 17.29
RNA-seq analysis of BAP1-depleted uveal melanoma cells 17.27
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 16.61
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 16.48
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 16.14
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 15.75
Primary Human B-cell Temporal Response to CD40L Stimulation 15.7
Functional role of SLIT2 and ROBO1 in trophoblasts 15.7
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 15.24
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 15.19
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 15.14
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 15.11
Differential gene expression of human melanoma cells [RNA-seq] 15.11
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 14.89
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 14.69
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 14.4
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 14.4
Bone marrow derived human B cells [normal proB] 13.88
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 13.84
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 13.61
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 13.54
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 13.54
RNA-seq of MCF10A cells and CAF 13.11
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 13.11
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 13.01
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 12.94
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 12.8
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 12.51
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 12.36
Landscape of H3K4me3 in human CD19 cells 12.27
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  12.18
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 12.15
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 11.58
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 10.88
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 10.6
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 10.6
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.58
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.58
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 10.15
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.15
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 10.05
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 10.02
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.8
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 9.56
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 9.36
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 9.29
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 9.25
Expression profiling of etoposide-induced senescent cells 9.23
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 9.16
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.71
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 8.7
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 8.54
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.51
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 8.16
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.11
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.03
Paxillin regulates genomic networks in prostate cancer [PC3] 7.83
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.68
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 7.58
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.53
RNA m5C Methylation in breast cancer using MeRIP-Seq 7.43
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 7.39
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 7.33
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 7.33
A sister of NANOG regulates genes expressed in pre-implantation human development 7.14
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 7.13
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.77
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.52
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 6.38
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 6.32
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 6.28
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.25
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.24
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.17
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.17
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 6.05
RNA-Seq analysis of breast cancer cells after shikonin treatment 6.02
RNA-seq analysis of control and Myc-induced U2OS cells 6.01
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 6.0
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 6.0
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 5.98
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 5.98
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 5.89
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 5.87
Overexpression and knockdown experiment for circCSNK1G3 5.68
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.68
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 5.64
ZIKV infection of monocytes activates inflammasome pathways 5.59
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.59
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 5.55
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 5.53
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 5.53
BACH2 in human plasma cell fate decision 5.5
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 5.48
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.47
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.38
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 5.36
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 5.28
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 5.28
Widespread intronic polyadenylation diversifies immune cell transcriptomes 5.25
Effect of Hotair overexpression in human breast cancer cell lines 5.01
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.0
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.93
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.92
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.79
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.79
naive T cell heterogeneity after neonatal thymectomy 4.78
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 4.75
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 4.58
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.52
Be1 and Be2 B cells are transcriptionally distinct 4.52
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.5
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.5
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.47
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 4.43
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.39
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.33
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.26
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 4.25
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.21
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 4.21
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 4.2
The role of FAM46C in myeloma cells 4.18
The role of FAM46C in myeloma cells [sequencing] 4.18
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 4.16
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 4.15
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 4.12
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 4.1
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.1
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.0
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.98
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.98
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 3.96
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.96
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 3.83
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.81
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.72
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.68
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.63
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.6
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 3.59
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.55
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 3.45
Transcriptome of activated human and mouse MAIT cells 3.44
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.39
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.26
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.23
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.23
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.19
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 3.19
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.18
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.18
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 3.15
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.15
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.09
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 3.06
An acquired vulnerability of drug resistant melanoma with therapeutic potential 3.06
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.04
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 3.01
Nucleoporin-mediated regulation of cell identity genes 2.92
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.9
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.87
Regulating Interleukin-2 activity with engineered receptor signaling clamps 2.8
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.78
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.77
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 2.72
Gene expression changes upon drug withdrawal (Mel888 cell line) 2.72
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.72
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.72
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.68
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 2.65
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.59
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.56
CircRNAome diversity in human mature B-cells, T-cells and monocytes 2.55
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.54
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.54
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.54
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.54
RNAseq of IL-36 stimulated primary human keratinocytes 2.52
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.51
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 2.5
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.47
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.46
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 2.44
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.44
Unique features and clinical importance of acute alloreactive immune responses 2.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.42
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 2.41
A single cell reference map for human blood and tissue T cell activation 2.4
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.35
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.35
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.35
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.29
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.29
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.27
The DNA methylation landscape of human melanoma 2.27
The DNA methylation landscape of human melanoma [RNA-Seq] 2.27
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.26
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.26
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.25
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.24
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 2.23
Polarized B -cell functions 2.22
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.22
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 2.12
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.12
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 2.09
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2.05
CROP-Seq in Primary Human T Cells 2.04
CD74 role in transcription regulation [RNA-seq] 2.04
CD74 role in transcription regulation 2.04
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 2.04
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.02
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 2.02
Interphase condensins regulate ligand-depedent enhancer activation 2.01
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 2.01
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.01
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.99
The cohesin complex prevents Myc-induced replication stress 1.96
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.95
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 1.95
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 1.95
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.92
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.92
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.92
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.87
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 1.86
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 1.84
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 1.82
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.8
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.8
The evolution of N6-methyladenosine in primates 1.8
Transcriptional profile in human S. haematobium infection 1.8
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 1.77
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.77
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.77
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.76
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.76
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.74
Dysregulated immune system networks in war veterans with PTSD 1.74
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 1.71
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.64
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.64
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 1.64
Chromatin-informed inference of transcriptional programs in gynecologic cancers 1.63
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 1.63
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.63
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 1.57
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 1.55
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.55
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 1.54
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 1.54
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 1.51
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 1.5
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 1.46
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.44
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.43
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 1.43
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.42
Identification of global regulators of T-helper cell lineage specification 1.4
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.4
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.39
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.39
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.39
RNA-Seq and expression data from human adipose tissue 1.39
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 1.39
LncRNA expression profiling of ischemic stroke patients 1.38
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 1.36
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.36
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.36
Direct Isolation and Characterization of Human Nephron Progenitors. 1.34
Real-time observation of light-controlled transcription in living cells 1.34
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.33
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.33
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.33
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.32
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.29
Gene expression signatures of innate lymphoid cells from human blood 1.28
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 1.27
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 1.27
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.26
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.26
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.26
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.26
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 1.24
Clinker: visualizing fusion genes detected in RNA-seq data 1.23
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.21
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.19
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 1.18
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 1.18
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 1.16
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.15
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.12
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 1.12
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.1
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.1
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.1
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.1
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.09
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 1.08
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 1.08
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 1.07
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.07
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.07
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.07
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.03
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.01
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.01
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.01
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 1.0
Discovering human diabetes-risk gene function with genetics and physiological assays 0.99
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.98
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.94
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.94
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.91
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.91
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.89
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.89
Total RNA-Seq data from leukemic patients with complex structural variants 0.88
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.88
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.88
Role of microRNAs in the interaction between Salmonella and the host cell 0.87
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.87
RNA-Seq from human ILC transitional populations 0.87
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.84
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.84
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 0.83
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.83
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 0.83
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.82
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.81
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.81
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.81
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 0.79
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.78
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.78
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.78
Transcriptome analyses of human pancreatic islets and pseudoislets 0.78
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.77
RNA-seq in endometrial stromal tumors 0.77
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.77
The bromodomain protein BRD4 regulates splicing during heat shock 0.74
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 0.73
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.73
Hepatosplenic T cell lymphoma 0.72
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.72
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.71
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.71
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.7
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.69
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.68
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.68
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 0.68
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.67
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.66
Gene expression analysis of breast cancer cell-lines 0.66
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.64
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.63
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.63
mRNA sequencing of oropharyngeal cancer cell lines 0.63
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.63
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.63
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.63
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.62
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.61
RNA-seq of IL-4 stimulated human keratinocytes 0.61
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.6
quanTIseq: quantifying immune contexture of human tumors 0.6
CSL 0.58
CSL RNA-Seq on HKC and SCC cell lines 0.58
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.56
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 0.55
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.54
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.54
The expression profiles of GBC liver metastasis 0.5
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.5
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.49
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.49
The Genomic Landscape of Atypical Fibroxanthoma 0.49
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.48
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.48
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 0.47
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.47
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.46
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.46
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.46
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 0.46
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.44
Single cell transcriptome of peritoneal cells 0.44
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.43
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.42
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.4
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.4
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.39
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.39
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.38
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.38
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.38
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.38
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.38
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.38
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.38
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.38
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.37
Common inflammatory pathways between NEC and Crohn's disease 0.37
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 0.35
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.34
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.34
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.33
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.32
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.32
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.3
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.3
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.3
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.3
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.3
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.3
Intron retention induced by microsatellite expansions as a disease biomarker. 0.29
MHC Transcriptomic landscape at haplotype-specific resolution 0.29
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.29
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.28
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.28
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.26
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 0.26
Expression analysis of the TAF1 syndrome 0.25
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.24
Transcriptomic analyssis following EHMT1/2 inhibition 0.23
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.23
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.22
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.22
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.22
MAIT cell RNA sequencing 0.21
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.2
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.2
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 0.19
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.16
Gene expression activation in CLL mediated by MSCs contact 0.16
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.15
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.15
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.15
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.14
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.13
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.11
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.09
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.08
RNA-seq data 0.08
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.05
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.05
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.03
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.03
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.02
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.02
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.02
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation